| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0034 |
0.9 |
| mRNA |
CCT018159 |
GDSC1000 |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
Bexarotene |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
| mRNA |
JQ-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0031 |
0.9 |
| mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
Parthenolide |
GDSC1000 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
| mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0033 |
0.9 |
| mRNA |
Tamoxifen |
CTRPv2 |
pan-cancer |
AAC |
0.0036 |
0.9 |
| mRNA |
BRD-A86708339 |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |